Talaris Therapeutics Inc (TALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TALS | ACHV | SAVA | ||
| Company | Talaris Therapeutics Inc | Achieve Life Sciences Inc | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.80 | 3.80 | 2.24 | ||
| High | 27.95 | 3.96 | 2.41 | ||
| Low | 26.90 | 3.60 | 2.23 | ||
| Last | 27.20 | 3.69 | 2.35 | ||
| Change | -0.20 | -0.13 | +0.06 | ||
| % Change | -0.73% | -3.40% | +2.62% | ||
| Volume | 30,520 | 476,900 | 3,200,800 | ||
| 20-Day Average Volume | 179,555 | 142,215 | 12,464,260 | ||
| Previous Close | 27.40 | 3.82 | 2.29 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.76 | 4.29 | 4.25 | ||
| 20-Day Raw Stochastic | 31.67% | 8.53% | 0.41% | ||
| 20-Day Relative Strength | 46.92% | 31.21% | 26.14% | ||
| Weighted Alpha | +66.50 | -14.05 | -73.41 | ||
| Today's Opinion | Hold | 96% Sell | 88% Sell | ||
| Previous Opinion | 8% Buy | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 48% Buy | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.74% since 10/12/23 | -10.00% since 12/13/24 | -14.55% since 12/13/24 | ||
| Low | 2.60 on 10/18/23 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 3.13 on 10/16/23 | 4.20 on 12/18/24 | 2.83 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -6.85% since 09/19/23 | -14.29% since 11/20/24 | -90.98% since 11/20/24 | ||
| Low | 2.53 on 10/10/23 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 3.13 on 10/16/23 | 4.66 on 12/10/24 | 33.98 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -9.63% since 07/19/23 | -19.78% since 09/20/24 | -92.11% since 09/20/24 | ||
| Low | 2.53 on 10/10/23 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 3.13 on 10/16/23 | 5.31 on 11/06/24 | 33.98 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +23.64% since 04/19/23 | -21.32% since 06/20/24 | -88.24% since 06/20/24 | ||
| Low | 2.15 on 04/20/23 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 3.29 on 07/10/23 | 5.31 on 11/06/24 | 42.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 116,318 | 126,899 | 113,059 | ||
| Shares Outstanding, K | 42,764 | 34,390 | 48,110 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -73,890,000 | -29,820,000 | -97,220,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -14,740,000 | -12,510,000 | -27,940,000 | ||
| 60-Month Beta | 2.18 | 1.58 | -0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 08/14/23 | -0.36 on 11/07/24 | -0.58 on 11/07/24 | ||
| Latest Earnings Date | 11/09/23 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||